| Product Code: ETC9690186 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Neurology Clinical Trials Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Neurology Clinical Trials Market - Industry Life Cycle |
3.4 Thailand Neurology Clinical Trials Market - Porter's Five Forces |
3.5 Thailand Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Thailand Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 Thailand Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Thailand Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Thailand |
4.2.2 Growing investment in healthcare infrastructure and research facilities |
4.2.3 Rising awareness about the importance of clinical trials for neurological treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for conducting clinical trials in Thailand |
4.3.2 Limited access to advanced technology and expertise in neurology research |
5 Thailand Neurology Clinical Trials Market Trends |
6 Thailand Neurology Clinical Trials Market, By Types |
6.1 Thailand Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Thailand Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Thailand Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 Thailand Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 Thailand Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 Thailand Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Thailand Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 Thailand Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Thailand Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 Thailand Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 Thailand Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Thailand Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 Thailand Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Thailand Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 Thailand Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 Thailand Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 Thailand Neurology Clinical Trials Market Export to Major Countries |
7.2 Thailand Neurology Clinical Trials Market Imports from Major Countries |
8 Thailand Neurology Clinical Trials Market Key Performance Indicators |
8.1 Patient recruitment rates for neurology clinical trials |
8.2 Number of successful trial completions within the specified timeline |
8.3 Rate of adoption of innovative neurology clinical trial methodologies |
8.4 Percentage of trials meeting regulatory approval timelines |
9 Thailand Neurology Clinical Trials Market - Opportunity Assessment |
9.1 Thailand Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Thailand Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 Thailand Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Thailand Neurology Clinical Trials Market - Competitive Landscape |
10.1 Thailand Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Thailand Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here